SUBRATA SEN to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications SUBRATA SEN has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.072
-
Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta. 2010 Oct-Dec; 1799(10-12):829-39.
Score: 0.072
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.